In Nucleic Acids Research this week: model to determine methylation effects of noncoding variants, Neisseria meningitides transcriptomics, and more.
An independent review panel calls on the Canadian government to increase its science funding by a billion dollars, according to Nature News.
Giant viruses may have developed from smaller viruses while also vacuuming up host genes, according to Ars Technica.
An Australian team has sequenced and mapped the genome of a prostate cancer tumor, as the Australian Financial Review reports.
In PNAS this week: genetic hints of adaptive evolution in Atlantic herring, ancestry of ancient individuals from the Pacific Northwest, and more.
CNBC reports that Google's parent company is wooing researchers from the healthcare and life science fields.
Two research teams uncover genetic variants that influence sleep, the Guardian reports.
Model organisms don't always represent what's going on in humans, NPR writes.
In PLOS this week: variants linked to risk of preterm birth, microbiome of New York's money, and more.
Both Republicans and Democrats are wary of proposed cuts to the NIH budget, the New York Times reports.
23andMe can again sell its direct-to-consumer genetic health risk tests after obtaining FDA authorization.
The movement to improve reproducibility in science could be used against the field, Ed Yong writes at the Atlantic.
In Science this week: method for designing stable CRISPR-based gene drives, and more.
An analysis in the New England Journal of Medicine finds that the US Food and Drug Administration reviews new drugs faster than the European Medicines Agency.
Climate change is leaving its mark on organisms and their genomes, according to the Guardian.
Elizabeth Holmes, the founder of Theranos, owes the firm millions, the Wall Street Journal reports.
In Nature this week: crown-of-thorns starfish genome, analysis of weedy rice genome, and more.
The University of California, San Diego's Cliff Kapono is collecting microbial samples from surfers, the New York Times reports.
Nature News reports that "precision public health" may aid healthcare approaches in Africa.
Former Vice President Joe Biden says cutting the NIH budget would delay cancer research, Live Science reports.
In Cell this week: genomic events that could make attenuated polio virulent, formation of regulatory RNAs, and more.
Retraction Watch reports that PNAS has issued expressions of concern about two papers from Ohio State's Carlo Croce.
Scott Gottlieb, President Donald Trump's choice to lead FDA, favors deregulation, an opinion piece at Stat News notes.
Researchers in Australia hope the genetic study will help take the guesswork out of prescribing medications for depression, the Hack says.
In PNAS this week: high-altitude adaptation signature among Tibetans, de novo mutations in early-onset high myopia, and more.
A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.
Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.
CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.
Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.